CELLULARLINE SPA (CELL.MI) Fundamental Analysis & Valuation
BIT:CELL • IT0005244618
Current stock price
2.225 EUR
+0 (+0.23%)
Last:
This CELL.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CELL.MI Profitability Analysis
1.1 Basic Checks
- In the past year CELL has reported negative net income.
- In the past year CELL had a positive cash flow from operations.
- In multiple years CELL reported negative net income over the last 5 years.
- Each year in the past 5 years CELL had a positive operating cash flow.
1.2 Ratios
- With a Return On Assets value of -20.20%, CELL is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
- With a Return On Equity value of -36.26%, CELL is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
- CELL has a Return On Invested Capital (5.01%) which is in line with its industry peers.
- CELL had an Average Return On Invested Capital over the past 3 years of 2.92%. This is significantly below the industry average of 17.47%.
- The last Return On Invested Capital (5.01%) for CELL is above the 3 year average (2.92%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.2% | ||
| ROE | -36.26% | ||
| ROIC | 5.01% |
ROA(3y)-5.63%
ROA(5y)-10.63%
ROE(3y)-10.27%
ROE(5y)-18.06%
ROIC(3y)2.92%
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 3.42%, CELL is doing worse than 60.61% of the companies in the same industry.
- In the last couple of years the Operating Margin of CELL has grown nicely.
- The Gross Margin of CELL (40.98%) is better than 60.61% of its industry peers.
- In the last couple of years the Gross Margin of CELL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.42% | ||
| PM (TTM) | N/A | ||
| GM | 40.98% |
OM growth 3YN/A
OM growth 5Y31.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.54%
GM growth 5Y-1.18%
2. CELL.MI Health Analysis
2.1 Basic Checks
- CELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, CELL has less shares outstanding
- Compared to 5 years ago, CELL has less shares outstanding
- CELL has a worse debt/assets ratio than last year.
2.2 Solvency
- CELL has an Altman-Z score of 2.93. This is not the best score and indicates that CELL is in the grey zone with still only limited risk for bankruptcy at the moment.
- CELL's Altman-Z score of 2.93 is fine compared to the rest of the industry. CELL outperforms 69.70% of its industry peers.
- CELL has a debt to FCF ratio of 2.29. This is a good value and a sign of high solvency as CELL would need 2.29 years to pay back of all of its debts.
- The Debt to FCF ratio of CELL (2.29) is better than 78.79% of its industry peers.
- A Debt/Equity ratio of 0.15 indicates that CELL is not too dependend on debt financing.
- CELL's Debt to Equity ratio of 0.15 is amongst the best of the industry. CELL outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.29 | ||
| Altman-Z | 2.93 |
ROIC/WACC0.66
WACC7.64%
2.3 Liquidity
- A Current Ratio of 2.20 indicates that CELL has no problem at all paying its short term obligations.
- CELL has a Current ratio of 2.20. This is amongst the best in the industry. CELL outperforms 84.85% of its industry peers.
- CELL has a Quick Ratio of 1.53. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
- CELL's Quick ratio of 1.53 is amongst the best of the industry. CELL outperforms 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.53 |
3. CELL.MI Growth Analysis
3.1 Past
- CELL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -764.12%.
- CELL shows a decrease in Revenue. In the last year, the revenue decreased by -3.88%.
- CELL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.42% yearly.
EPS 1Y (TTM)-764.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-619.22%
Revenue 1Y (TTM)-3.88%
Revenue growth 3Y4.4%
Revenue growth 5Y8.42%
Sales Q2Q%-6.01%
3.2 Future
- CELL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.99% yearly.
- Based on estimates for the next years, CELL will show a small growth in Revenue. The Revenue will grow by 1.71% on average per year.
EPS Next Y0%
EPS Next 2Y2.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.9%
Revenue Next 2Y1.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. CELL.MI Valuation Analysis
4.1 Price/Earnings Ratio
- CELL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- CELL is valuated cheaply with a Price/Forward Earnings ratio of 6.61.
- Based on the Price/Forward Earnings ratio, CELL is valued cheaply inside the industry as 87.88% of the companies are valued more expensively.
- CELL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 6.61 |
4.2 Price Multiples
- 100.00% of the companies in the same industry are more expensive than CELL, based on the Enterprise Value to EBITDA ratio.
- CELL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CELL is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.54 | ||
| EV/EBITDA | 0.87 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.99%
EPS Next 3YN/A
5. CELL.MI Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.72%, CELL is a good candidate for dividend investing.
- CELL's Dividend Yield is rather good when compared to the industry average which is at 1.04. CELL pays more dividend than 90.91% of the companies in the same industry.
- CELL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.72% |
5.2 History
- The dividend of CELL decreases each year by -20.42%.
Dividend Growth(5Y)-20.42%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- The earnings of CELL are negative and hence is the payout ratio. CELL will probably not be able to sustain this dividend level.
DP-5.54%
EPS Next 2Y2.99%
EPS Next 3YN/A
CELL.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:CELL (4/28/2026, 10:50:22 AM)
2.225
+0 (+0.23%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)03-09 2026-03-09
Earnings (Next)05-05 2026-05-05
Inst Owners4.94%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap48.66M
Revenue(TTM)231.79M
Net Income(TTM)-35.05M
Analysts82.86
Price Target3.98 (78.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.72% |
Yearly Dividend0.09
Dividend Growth(5Y)-20.42%
DP-5.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.88%
PT rev (3m)-4.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-21.43%
EPS NY rev (3m)-21.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-4.24%
Revenue NY rev (3m)-4.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 6.61 | ||
| P/S | 0.21 | ||
| P/FCF | 3.54 | ||
| P/OCF | 2.51 | ||
| P/B | 0.5 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 0.87 |
EPS(TTM)-1.68
EYN/A
EPS(NY)0.34
Fwd EY15.13%
FCF(TTM)0.63
FCFY28.22%
OCF(TTM)0.89
OCFY39.82%
SpS10.6
BVpS4.42
TBVpS2.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.2% | ||
| ROE | -36.26% | ||
| ROCE | 6.69% | ||
| ROIC | 5.01% | ||
| ROICexc | 6.28% | ||
| ROICexgc | 9.75% | ||
| OM | 3.42% | ||
| PM (TTM) | N/A | ||
| GM | 40.98% | ||
| FCFM | 5.92% |
ROA(3y)-5.63%
ROA(5y)-10.63%
ROE(3y)-10.27%
ROE(5y)-18.06%
ROIC(3y)2.92%
ROIC(5y)N/A
ROICexc(3y)3.5%
ROICexc(5y)N/A
ROICexgc(3y)7.94%
ROICexgc(5y)N/A
ROCE(3y)3.89%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y44.53%
ROICexc growth 3YN/A
ROICexc growth 5Y73.05%
OM growth 3YN/A
OM growth 5Y31.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.54%
GM growth 5Y-1.18%
F-Score5
Asset Turnover1.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.29 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 10.1% | ||
| Cap/Sales | 2.44% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.36% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.53 | ||
| Altman-Z | 2.93 |
F-Score5
WACC7.64%
ROIC/WACC0.66
Cap/Depr(3y)28.42%
Cap/Depr(5y)23.36%
Cap/Sales(3y)3.31%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-764.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-619.22%
EPS Next Y0%
EPS Next 2Y2.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.88%
Revenue growth 3Y4.4%
Revenue growth 5Y8.42%
Sales Q2Q%-6.01%
Revenue Next Year0.9%
Revenue Next 2Y1.71%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.14%
EBIT growth 3YN/A
EBIT growth 5Y43.02%
EBIT Next Year47.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.36%
FCF growth 3Y266.02%
FCF growth 5Y64.61%
OCF growth 1Y-9.99%
OCF growth 3Y58.25%
OCF growth 5Y11.38%
CELLULARLINE SPA / CELL.MI Fundamental Analysis FAQ
What is the ChartMill fundamental rating of CELLULARLINE SPA (CELL.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CELL.MI.
What is the valuation status for CELL stock?
ChartMill assigns a valuation rating of 5 / 10 to CELLULARLINE SPA (CELL.MI). This can be considered as Fairly Valued.
How profitable is CELLULARLINE SPA (CELL.MI) stock?
CELLULARLINE SPA (CELL.MI) has a profitability rating of 3 / 10.
How financially healthy is CELLULARLINE SPA?
The financial health rating of CELLULARLINE SPA (CELL.MI) is 7 / 10.
Can you provide the dividend sustainability for CELL stock?
The dividend rating of CELLULARLINE SPA (CELL.MI) is 5 / 10 and the dividend payout ratio is -5.54%.